Kisoji
2 known investors
Find your way into Kisoji
Sign up to see every warm intro you have to Kisoji
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Kisoji team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
KisoJi Biotechnology discovers and develops differentiated antibody therapeutics targeting difficult targets in oncology and other diseases. Its platform combines proprietary multi-species single domain antibody transgenic mice, AI-enabled antibody fingerprinting, and multi-specific antibody engineering for therapeutic, diagnostic, and vaccine development.
Investors · 2
Related companies · 1
Companies working in the same space as Kisoji.
Frequently asked questions
- What does Kisoji do?
- KisoJi Biotechnology discovers and develops differentiated antibody therapeutics targeting difficult targets in oncology and other diseases. Its platform combines proprietary multi-species single domain antibody transgenic mice, AI-enabled antibody fingerprinting, and multi-specific antibody engineering for therapeutic, diagnostic, and vaccine development.
- Who are Kisoji's investors?
- Kisoji's investors include Lumira Ventures, Remiges Ventures, Inc..